
GW Pharmaceuticals plc GWPH
GW Pharmaceuticals plc DPO Ratio 2011-2025 | GWPH
Annual DPO Ratio GW Pharmaceuticals plc
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 213 | 134 | 594 | 599 | 461 | 529 | 415 | 971 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 971 | 134 | 489 |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
405 | $ 1.15 | -1.71 % | $ 6.27 M | ||
|
Arbutus Biopharma Corporation
ABUS
|
23 | $ 4.78 | -0.31 % | $ 793 M | ||
|
Aclaris Therapeutics
ACRS
|
887 | $ 3.03 | -0.49 % | $ 234 M | ||
|
AIkido Pharma
AIKI
|
32.8 K | - | 1.93 % | $ 17.4 M | ||
|
Ampio Pharmaceuticals
AMPE
|
2.85 K | - | -11.43 % | $ 502 K | ||
|
Aptevo Therapeutics
APVO
|
239 | $ 0.6 | -35.8 % | $ 166 K | ||
|
BioDelivery Sciences International
BDSI
|
96.3 | - | -4.8 % | $ 255 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Acasti Pharma
ACST
|
4.39 K | - | 4.01 % | $ 150 M | ||
|
Berkeley Lights
BLI
|
135 | - | -7.31 % | $ 87 M | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
28.5 | $ 27.09 | 1.04 % | $ 1.31 B | ||
|
BeiGene, Ltd.
BGNE
|
915 | - | 0.49 % | $ 251 B | ||
|
Anika Therapeutics
ANIK
|
54.4 | $ 9.6 | 1.27 % | $ 141 M | ||
|
bluebird bio
BLUE
|
182 | - | - | $ 546 M | ||
|
Zai Lab Limited
ZLAB
|
265 | $ 18.4 | -0.97 % | $ 18.2 B | ||
|
Catalyst Biosciences
CBIO
|
18.8 | $ 12.33 | -0.29 % | $ 812 M | ||
|
Arena Pharmaceuticals
ARNA
|
142 | - | -6.81 % | $ 3.04 B | ||
|
Axon Enterprise
AXON
|
29.9 | $ 584.81 | -1.07 % | $ 44.3 B | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
186 | $ 2.44 | -3.56 % | $ 15.3 M | ||
|
AstraZeneca PLC
AZN
|
265 | $ 92.79 | 0.37 % | $ 96.9 B | ||
|
ChromaDex Corporation
CDXC
|
90.1 | - | -0.88 % | $ 598 M | ||
|
Certara
CERT
|
10.2 | $ 8.9 | -0.17 % | $ 1.43 B | ||
|
Acorda Therapeutics
ACOR
|
277 | - | -24.86 % | $ 820 K |